questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Hydrolases
Aminohydrolases
Aminohydrolases : Questions médicales fréquentes
Diagnostic
5
Déficience enzymatique
Tests sanguins
Tests enzymatiques
Aminohydrolases
Troubles métaboliques
Symptômes
Tests génétiques
Mutations
Évaluation clinique
Bilan biochimique
Symptômes
5
Déficience enzymatique
Symptômes
Douleurs abdominales
Troubles métaboliques
Troubles neurologiques
Retards de développement
Types d'enzymes
Symptômes
Prévention
5
Prévention
Détection précoce
Conseils génétiques
Transmission
Alimentation
Santé métabolique
Dépistage néonatal
Déficiences enzymatiques
Traitements
5
Traitements
Suppléments enzymatiques
Régime alimentaire
Qualité de vie
Thérapie génique
Recherche
Médicaments
Traitements symptomatiques
Complications
5
Complications
Troubles métaboliques
Risque
Maladies métaboliques
Prévention
Soins médicaux
Qualité de vie
Complications
Facteurs de risque
5
Facteurs de risque
Antécédents familiaux
Facteurs environnementaux
Prédispositions génétiques
Maladies métaboliques
Risque
Habitudes alimentaires
Symptômes
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Aminohydrolases : Questions médicales les plus fréquentes",
"headline": "Aminohydrolases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Aminohydrolases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-01",
"dateModified": "2026-02-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Aminohydrolases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hydrolases",
"url": "https://questionsmedicales.fr/mesh/D006867",
"about": {
"@type": "MedicalCondition",
"name": "Hydrolases",
"code": {
"@type": "MedicalCode",
"code": "D006867",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "GTP cyclohydrolase I",
"alternateName": "GTP Cyclohydrolase",
"url": "https://questionsmedicales.fr/mesh/D006136",
"about": {
"@type": "MedicalCondition",
"name": "GTP cyclohydrolase I",
"code": {
"@type": "MedicalCode",
"code": "D006136",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.151.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Guanine deaminase",
"alternateName": "Guanine Deaminase",
"url": "https://questionsmedicales.fr/mesh/D006148",
"about": {
"@type": "MedicalCondition",
"name": "Guanine deaminase",
"code": {
"@type": "MedicalCode",
"code": "D006148",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.151.350"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Methenyltetrahydrofolate cyclohydrolase",
"alternateName": "Methenyltetrahydrofolate Cyclohydrolase",
"url": "https://questionsmedicales.fr/mesh/D045064",
"about": {
"@type": "MedicalCondition",
"name": "Methenyltetrahydrofolate cyclohydrolase",
"code": {
"@type": "MedicalCode",
"code": "D045064",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.151.418"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nucleoside deaminases",
"alternateName": "Nucleoside Deaminases",
"url": "https://questionsmedicales.fr/mesh/D009700",
"about": {
"@type": "MedicalCondition",
"name": "Nucleoside deaminases",
"code": {
"@type": "MedicalCode",
"code": "D009700",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.151.486"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Adenosine deaminase",
"alternateName": "Adenosine Deaminase",
"url": "https://questionsmedicales.fr/mesh/D000243",
"about": {
"@type": "MedicalCondition",
"name": "Adenosine deaminase",
"code": {
"@type": "MedicalCode",
"code": "D000243",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.151.486.075"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cytidine deaminase",
"alternateName": "Cytidine Deaminase",
"url": "https://questionsmedicales.fr/mesh/D003564",
"about": {
"@type": "MedicalCondition",
"name": "Cytidine deaminase",
"code": {
"@type": "MedicalCode",
"code": "D003564",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.151.486.250"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "APOBEC Deaminases",
"alternateName": "APOBEC Deaminases",
"url": "https://questionsmedicales.fr/mesh/D000071478",
"about": {
"@type": "MedicalCondition",
"name": "APOBEC Deaminases",
"code": {
"@type": "MedicalCode",
"code": "D000071478",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.151.486.250.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "APOBEC-1 Deaminase",
"alternateName": "APOBEC-1 Deaminase",
"url": "https://questionsmedicales.fr/mesh/D000071479",
"about": {
"@type": "MedicalCondition",
"name": "APOBEC-1 Deaminase",
"code": {
"@type": "MedicalCode",
"code": "D000071479",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.151.486.250.500.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "APOBEC-1 Deaminase",
"alternateName": "APOBEC-1 Deaminase",
"url": "https://questionsmedicales.fr/mesh/D000071479",
"about": {
"@type": "MedicalCondition",
"name": "APOBEC-1 Deaminase",
"code": {
"@type": "MedicalCode",
"code": "D000071479",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.151.486.250.500.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "APOBEC Deaminases",
"alternateName": "APOBEC Deaminases",
"url": "https://questionsmedicales.fr/mesh/D000071478",
"about": {
"@type": "MedicalCondition",
"name": "APOBEC Deaminases",
"code": {
"@type": "MedicalCode",
"code": "D000071478",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.151.486.250.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "APOBEC-1 Deaminase",
"alternateName": "APOBEC-1 Deaminase",
"url": "https://questionsmedicales.fr/mesh/D000071479",
"about": {
"@type": "MedicalCondition",
"name": "APOBEC-1 Deaminase",
"code": {
"@type": "MedicalCode",
"code": "D000071479",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.151.486.250.500.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "APOBEC-1 Deaminase",
"alternateName": "APOBEC-1 Deaminase",
"url": "https://questionsmedicales.fr/mesh/D000071479",
"about": {
"@type": "MedicalCondition",
"name": "APOBEC-1 Deaminase",
"code": {
"@type": "MedicalCode",
"code": "D000071479",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.151.486.250.500.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cytosine deaminase",
"alternateName": "Cytosine Deaminase",
"url": "https://questionsmedicales.fr/mesh/D043525",
"about": {
"@type": "MedicalCondition",
"name": "Cytosine deaminase",
"code": {
"@type": "MedicalCode",
"code": "D043525",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.151.486.625"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Nucleotide deaminases",
"alternateName": "Nucleotide Deaminases",
"url": "https://questionsmedicales.fr/mesh/D009709",
"about": {
"@type": "MedicalCondition",
"name": "Nucleotide deaminases",
"code": {
"@type": "MedicalCode",
"code": "D009709",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.151.653"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "AMP deaminase",
"alternateName": "AMP Deaminase",
"url": "https://questionsmedicales.fr/mesh/D000659",
"about": {
"@type": "MedicalCondition",
"name": "AMP deaminase",
"code": {
"@type": "MedicalCode",
"code": "D000659",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.151.653.060"
}
}
},
{
"@type": "MedicalWebPage",
"name": "DCMP deaminase",
"alternateName": "DCMP Deaminase",
"url": "https://questionsmedicales.fr/mesh/D003844",
"about": {
"@type": "MedicalCondition",
"name": "DCMP deaminase",
"code": {
"@type": "MedicalCode",
"code": "D003844",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.151.653.200"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Aminohydrolases",
"alternateName": "Aminohydrolases",
"code": {
"@type": "MedicalCode",
"code": "D000619",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Firdous Butt",
"url": "https://questionsmedicales.fr/author/Firdous%20Butt",
"affiliation": {
"@type": "Organization",
"name": "Department of Biotechnology, Quaid-i-Azam University, Islamabad, Pakistan."
}
},
{
"@type": "Person",
"name": "Masoom Yasinzai",
"url": "https://questionsmedicales.fr/author/Masoom%20Yasinzai",
"affiliation": {
"@type": "Organization",
"name": "International Islamic University, Islamabad, Pakistan."
}
},
{
"@type": "Person",
"name": "Shaukat Iqbal Malik",
"url": "https://questionsmedicales.fr/author/Shaukat%20Iqbal%20Malik",
"affiliation": {
"@type": "Organization",
"name": "Department of Bioinformatics and Biosciences, Capital University of Science and Technology, Islamabad, Pakistan."
}
},
{
"@type": "Person",
"name": "Anum Munir",
"url": "https://questionsmedicales.fr/author/Anum%20Munir",
"affiliation": {
"@type": "Organization",
"name": "Department of Bioinformatics and Biosciences, Capital University of Science and Technology, Islamabad, Pakistan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Reduced Oxidative Phosphorylation and Increased Glycolysis in Human Glaucoma Lamina Cribrosa Cells.",
"datePublished": "2020-11-02",
"url": "https://questionsmedicales.fr/article/33137197",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1167/iovs.61.13.4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Integrated bioinformatics analysis identified MTHFD1L as a potential biomarker and correlated with immune infiltrates in hepatocellular carcinoma.",
"datePublished": "2021-02-26",
"url": "https://questionsmedicales.fr/article/33605411",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1042/BSR20202063"
}
},
{
"@type": "ScholarlyArticle",
"name": "Risk factors associated with outcomes of peritoneal dialysis in Taiwan: An analysis using a competing risk model.",
"datePublished": "2019-Feb-00",
"url": "https://questionsmedicales.fr/article/30732176",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MD.0000000000014385"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evolution of new enzymes by gene duplication and divergence.",
"datePublished": "2020-04-00",
"url": "https://questionsmedicales.fr/article/32250558",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/febs.15299"
}
},
{
"@type": "ScholarlyArticle",
"name": "In vivo evaluation of the interaction between the Escherichia coli IGP synthase subunits using the Bacterial Two-Hybrid system.",
"datePublished": "2020-07-01",
"url": "https://questionsmedicales.fr/article/32614412",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/femsle/fnaa112"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrolases",
"item": "https://questionsmedicales.fr/mesh/D006867"
},
{
"@type": "ListItem",
"position": 5,
"name": "Aminohydrolases",
"item": "https://questionsmedicales.fr/mesh/D000619"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Aminohydrolases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Aminohydrolases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Aminohydrolases",
"description": "Comment diagnostiquer une déficience en aminohydrolases ?\nQuels tests sont utilisés pour évaluer l'activité des aminohydrolases ?\nQuels symptômes peuvent indiquer un problème d'aminohydrolases ?\nLes tests génétiques sont-ils utiles pour les aminohydrolases ?\nComment évaluer l'impact des aminohydrolases sur la santé ?",
"url": "https://questionsmedicales.fr/mesh/D000619#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Aminohydrolases",
"description": "Quels sont les symptômes d'une déficience en aminohydrolases ?\nLes douleurs abdominales sont-elles liées aux aminohydrolases ?\nPeut-on avoir des troubles neurologiques avec des déficiences en aminohydrolases ?\nLes symptômes varient-ils selon le type d'aminohydrolase ?\nLes symptômes sont-ils immédiats ou progressifs ?",
"url": "https://questionsmedicales.fr/mesh/D000619#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Aminohydrolases",
"description": "Peut-on prévenir les déficiences en aminohydrolases ?\nLes conseils génétiques sont-ils utiles pour les familles à risque ?\nL'alimentation peut-elle prévenir des troubles liés aux aminohydrolases ?\nLes dépistages néonatals incluent-ils les aminohydrolases ?\nLes vaccinations influencent-elles les déficiences en aminohydrolases ?",
"url": "https://questionsmedicales.fr/mesh/D000619#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Aminohydrolases",
"description": "Quels traitements existent pour les déficiences en aminohydrolases ?\nLes régimes alimentaires peuvent-ils aider les déficiences en aminohydrolases ?\nLes thérapies géniques sont-elles une option pour ces déficiences ?\nLes médicaments peuvent-ils traiter les déficiences en aminohydrolases ?\nComment surveiller l'efficacité des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D000619#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Aminohydrolases",
"description": "Quelles complications peuvent survenir avec des déficiences en aminohydrolases ?\nLes complications sont-elles réversibles ?\nLes déficiences en aminohydrolases augmentent-elles le risque de maladies ?\nComment prévenir les complications liées aux déficiences ?\nLes complications affectent-elles la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D000619#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Aminohydrolases",
"description": "Quels sont les facteurs de risque pour les déficiences en aminohydrolases ?\nL'âge joue-t-il un rôle dans les déficiences en aminohydrolases ?\nLes facteurs environnementaux influencent-ils ces déficiences ?\nLes maladies métaboliques augmentent-elles le risque ?\nLes habitudes alimentaires influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D000619#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en aminohydrolases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des analyses enzymatiques peuvent révéler une déficience."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité des aminohydrolases ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests d'activité enzymatique in vitro sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème d'aminohydrolases ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles métaboliques, des douleurs abdominales ou des anomalies de croissance peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les aminohydrolases ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier des mutations génétiques liées à des déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'impact des aminohydrolases sur la santé ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation clinique et les bilans biochimiques sont essentiels pour comprendre leur impact."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en aminohydrolases ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, troubles digestifs et anomalies de croissance."
}
},
{
"@type": "Question",
"name": "Les douleurs abdominales sont-elles liées aux aminohydrolases ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs abdominales peuvent survenir en raison de troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des troubles neurologiques avec des déficiences en aminohydrolases ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines déficiences peuvent entraîner des troubles neurologiques, comme des retards de développement."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type d'aminohydrolase ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'aminohydrolase affectée et de son rôle."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils immédiats ou progressifs ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être progressifs, se manifestant au fil du temps selon la gravité de la déficience."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les déficiences en aminohydrolases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines déficiences sont héréditaires, mais une détection précoce peut aider à la gestion."
}
},
{
"@type": "Question",
"name": "Les conseils génétiques sont-ils utiles pour les familles à risque ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les conseils génétiques peuvent aider à évaluer le risque de transmission."
}
},
{
"@type": "Question",
"name": "L'alimentation peut-elle prévenir des troubles liés aux aminohydrolases ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé métabolique, mais ne prévient pas toutes les déficiences."
}
},
{
"@type": "Question",
"name": "Les dépistages néonatals incluent-ils les aminohydrolases ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains dépistages néonatals peuvent inclure des tests pour des déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Les vaccinations influencent-elles les déficiences en aminohydrolases ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccinations n'ont pas d'impact direct sur les déficiences en aminohydrolases."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les déficiences en aminohydrolases ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des suppléments enzymatiques et des régimes alimentaires spécifiques."
}
},
{
"@type": "Question",
"name": "Les régimes alimentaires peuvent-ils aider les déficiences en aminohydrolases ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un régime adapté peut réduire les symptômes et améliorer la qualité de vie."
}
},
{
"@type": "Question",
"name": "Les thérapies géniques sont-elles une option pour ces déficiences ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche, mais elle pourrait offrir des solutions futures."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils traiter les déficiences en aminohydrolases ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de médicaments spécifiques, mais des traitements symptomatiques sont possibles."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'efficacité des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des bilans réguliers et des tests d'activité enzymatique permettent de suivre l'efficacité."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des déficiences en aminohydrolases ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles métaboliques graves et des retards de développement."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Les déficiences en aminohydrolases augmentent-elles le risque de maladies ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent augmenter le risque de maladies métaboliques et neurologiques."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées aux déficiences ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une gestion proactive avec des soins médicaux réguliers peut aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les déficiences en aminohydrolases ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux et certaines mutations génétiques sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans les déficiences en aminohydrolases ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge peut influencer l'apparition des symptômes, mais les déficiences sont souvent héréditaires."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux influencent-ils ces déficiences ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs environnementaux peuvent interagir avec des prédispositions génétiques."
}
},
{
"@type": "Question",
"name": "Les maladies métaboliques augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies métaboliques peuvent être liées à des déficiences en aminohydrolases."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation déséquilibrée peut exacerber les symptômes, mais ne cause pas directement les déficiences."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/02/2026
Contenu vérifié selon les dernières recommandations médicales
1 publication dans cette catégorie
Affiliations :
Department of Biotechnology, Quaid-i-Azam University, Islamabad, Pakistan.
Publications dans "Aminohydrolases" :
1 publication dans cette catégorie
Affiliations :
International Islamic University, Islamabad, Pakistan.
Publications dans "Aminohydrolases" :
1 publication dans cette catégorie
Affiliations :
Department of Bioinformatics and Biosciences, Capital University of Science and Technology, Islamabad, Pakistan.
Publications dans "Aminohydrolases" :
1 publication dans cette catégorie
Affiliations :
Department of Bioinformatics and Biosciences, Capital University of Science and Technology, Islamabad, Pakistan.
Publications dans "Aminohydrolases" :
The lamina cribrosa (LC) is a key site of damage in glaucomatous optic neuropathy. We previously found that glaucoma LC cells have an increased profibrotic gene expression, with mitochondrial dysfunct...
LC cells from three glaucoma donors and three age-matched normal controls were assessed using VICTOR X4 Perkin Elmer (Waltham, MA) plate reader with different phosphorescent and luminescent probes. ad...
Glaucoma LC cells contain significantly less adenosine triphosphate (P < .05) when supplied with either glucose or galactose. They also showed significantly diminished oxygen consumption in both basal...
We demonstrate evidence of metabolic reprogramming (The Warburg effect) in glaucoma LC cells. Expression of markers of glycolysis, glutamine, and one carbon metabolism are elevated in glaucoma cells a...
Liver hepatocellular carcinoma (LIHC) is one of the most frequently occurring primary malignant liver tumors and seriously harms people's health in the world. Methylenetetrahydrofolate dehydrogenase 1...
Peritoneal dialysis (PD) is one option for renal replacement therapy in patients with end-stage renal disease (ESRD). Maintenance of the PD catheter is an important issue for patient outcomes and qual...
Thousands of new metabolic and regulatory enzymes have evolved by gene duplication and divergence since the dawn of life. New enzyme activities often originate from promiscuous secondary activities th...
Histidine biosynthesis is one of the most characterized metabolic routes for its antiquity and its central role in cellular metabolism; indeed, it represents a cross-road between nitrogen metabolism a...
To explore the clinical significance of circ-MTHFD2 in the diagnosis, pathological staging, and prognosis of non-small cell lung cancer (NSCLC)....
A total of 100 pairs of cancer tissues and adjacent tissues were surgically removed from NSCLC patients treated from July 2011 to January 2013 in our hospital were selected. All tissue samples were pa...
The expression of circ-MTHFD2 in cancer tissues of NSCLC patients was higher than that in adjacent tissues (p<0.05), and there was no remarkable difference in the expression of circ-MTHFD2 before and ...
The high expression of circ-MTHFD2 has clinical significance in the diagnosis, pathological staging, and prognosis of NSCLC....
Microbial nitrilases play a vital role in the biodegradation of nitrilecontaining pollutants, effluent treatments in chemical and textile industries, and the biosynthesis of Indole-3-acetic acid (IAA)...
The present study involves the genome mining of bacteria for the distribution and diversity of nitrilases, their phylogenetic analysis and structural characterization for motifs/ domains, followed by ...
Here, we mined the bacterial genomes for nitrilases and correlated their functions to hypothetical, uncharacterized, or putative ones. The comparative genomics revealed four AcNit, As7Nit, Cn5Nit and ...
The present study reports genome mining and simulation of structure-function relationship for uncharacterized bacterial nitrilases and their role in the biodegradation of pollutants and xenobiotics, w...
Deregulated expression of miRNAs contributes to the development of acute myeloid leukemia (AML). miR-504-3p, one of these miRNAs, has been found have upregulated expression in various human malignanci...
Real-time quantitative PCR was applied to evaluate the expression level of miR-504-3p in AML cell lines and the serum from AML cases. The correlations between miR-504-3p and AML patients' clinicopatho...
The expression levels of miR-504-3p were significantly down-regulated in the serum of AML patients and cell lines, and its low expression was positively associated with advanced clinical stages and po...
Our findings provide important evidence that supports the role of miR-504-3p as a tumor suppressor in AML via the inhibition of MTHFD2 expression....
Nitrilase is a valuable type of hydrolase that catalyzes nitriles into carboxylic acid and ammonia. Its applications, however, are severely restricted by the harsh conditions of industrial reaction pr...
DNA methylation is an important epigenetic regulatory mechanism in esophageal carcinoma (EC) and is associated with genomic instability and carcinogenesis. In the present study, we aimed to identify t...